Ca-4-methyl-2-oxo-valerate (α-ketoanalogue to leucine, Ca salt) 101 mg, Ca-3-methyl-2-oxo-butyrate (α-ketoanalogue to valine, Ca salt) 86 mg, Ca-2-oxo-3-phenylpropionate (α-ketoanalogue to phenylalanine, Ca salt) 68 mg, Ca-3-methyl-2-oxo-valerate (α-ketoanalogue to isoleucine, Ca salt) 67 mg, Ca-DL-2-hydroxy-4-(methylthio)butyrate (α-hydroxyanalogue to methionine, Ca salt) 59 mg, l-lysine acetate 105 mg, l-threonine 53 mg, l-histidine 38 mg, l-tyrosine 30 mg, l-tryptophan 23 mg
Indications/Uses
Prevention & treatment of damages due to faulty or deficient protein metabolism in CKD in connection w/ a limited dietary protein intake of ≤40 g daily (adults), usually applies to patients whose GFR is <25 mL/min.
Increased serum Ca levels w/ drugs containing Ca. Avoid concomitant administration of antacids containing Al hydroxide. Interference of absorption w/ antimicrobials eg, tetracyclines, ciprofloxacin, norfloxacin & Fe prep.